Sokol, you are so very correct in your comments. I have invested in biotech for many years and some patterns seem to always repeat themselves. The unbridled enthusiasm, the bashing, the frivolous law suits, the volatility, the many disappointments and frustrations along the way. As I and others have repeated on this board, successful early stage biotech investing is not easy and it requires one to be more rational than emotional.
I did the same thing you did with REGN, but actually sold it earlier than you did. I also have learned the painful lesson of getting married to a biotech and paying the price for that. I am cautiously optimistic about AVXL and will continue to add to my position as the data hopefully proves itself. As a retired MD who has worked with Alzheimer's patients, I desperately want our little company to succeed. So, emotionally, I am very invested in this company. But as an investor I take a more dispassionate and deliberate approach....simply due to lessons learned along the way.
News 
Market Data 
Discover 
